Javascript must be enabled to continue!
Impact of Macroscopic On-Site Evaluation (MOSE) on Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Biopsy (EUS-FNB) of Pancreatic and Extrapancreatic Solid Lesions: A Prospective Study
View through CrossRef
This is a prospective and comparative study including 76 consecutive patients performing EUS-FNB for pancreatic and extrapancreatic solid lesions, randomized by alternate allocation to macroscopic on-site evaluation (MOSE) (40 patients) or to a conventional technique (40 patients), with three passes each. MOSE samples were differentiated into score 0: no visible material, score 1: only necrotic or haematic material, score 2: white core tissue ≤ 2 mm, or score 3: white core tissue > 2 mm. The conventional technique consisted in pushing all the needle content into a test tube for evaluation by the pathologist. In both groups, a 22–25 Gauge Franseen-tip needle (Acquire, Boston Scientific Co., Natick, MA, USA) was used. The study evaluated the diagnostic accuracy and adequacy of MOSE compared to the conventional technique and whether MOSE could optimize the number of passes during EUS-FNB. Results: The analysis was performed on 76 patients (38 MOSE, 38 conventional). The overall diagnostic adequacy was 94.7% (72/76) and accuracy was 84.2% (64/76). The diagnostic accuracy was similar in the two groups: MOSE 86.8% (33/38 lesions), vs. conventional 81.6%, 31/38 lesions, p = 0.76). Regarding diagnostic adequacy, the MOSE technique was 97.4% (111/114 passes) compared to 92.1% (105/114 passes) with the conventional technique, p = 0.06. The accuracy increased according to the MOSE score evaluation: it was 43.5%, 65.5% and 78.3% in patients with score 1, score 2, and score 3, respectively. Moreover, if in the first two passes the MOSE score was 2 or 3, the accuracy was 82.6% (20/23), and upon adding a third pass, the accuracy increased to 87% (20/23), which was not significantly different from the general accuracy of the MOSE samples (86.8%) (p = 0.86). Conclusions: The MOSE score showed a comparable diagnostic accuracy to the conventional technique. However, MOSE allows endoscopists to perform an inspective evaluation of the material, tends to perform better than the conventional technique in terms of diagnostic adequacy, and may potentially reduce the number of passes.
Title: Impact of Macroscopic On-Site Evaluation (MOSE) on Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Biopsy (EUS-FNB) of Pancreatic and Extrapancreatic Solid Lesions: A Prospective Study
Description:
This is a prospective and comparative study including 76 consecutive patients performing EUS-FNB for pancreatic and extrapancreatic solid lesions, randomized by alternate allocation to macroscopic on-site evaluation (MOSE) (40 patients) or to a conventional technique (40 patients), with three passes each.
MOSE samples were differentiated into score 0: no visible material, score 1: only necrotic or haematic material, score 2: white core tissue ≤ 2 mm, or score 3: white core tissue > 2 mm.
The conventional technique consisted in pushing all the needle content into a test tube for evaluation by the pathologist.
In both groups, a 22–25 Gauge Franseen-tip needle (Acquire, Boston Scientific Co.
, Natick, MA, USA) was used.
The study evaluated the diagnostic accuracy and adequacy of MOSE compared to the conventional technique and whether MOSE could optimize the number of passes during EUS-FNB.
Results: The analysis was performed on 76 patients (38 MOSE, 38 conventional).
The overall diagnostic adequacy was 94.
7% (72/76) and accuracy was 84.
2% (64/76).
The diagnostic accuracy was similar in the two groups: MOSE 86.
8% (33/38 lesions), vs.
conventional 81.
6%, 31/38 lesions, p = 0.
76).
Regarding diagnostic adequacy, the MOSE technique was 97.
4% (111/114 passes) compared to 92.
1% (105/114 passes) with the conventional technique, p = 0.
06.
The accuracy increased according to the MOSE score evaluation: it was 43.
5%, 65.
5% and 78.
3% in patients with score 1, score 2, and score 3, respectively.
Moreover, if in the first two passes the MOSE score was 2 or 3, the accuracy was 82.
6% (20/23), and upon adding a third pass, the accuracy increased to 87% (20/23), which was not significantly different from the general accuracy of the MOSE samples (86.
8%) (p = 0.
86).
Conclusions: The MOSE score showed a comparable diagnostic accuracy to the conventional technique.
However, MOSE allows endoscopists to perform an inspective evaluation of the material, tends to perform better than the conventional technique in terms of diagnostic adequacy, and may potentially reduce the number of passes.
Related Results
Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next‐generation sequencing acquired by endoscopic ultrasound–guided FNA and FNB
Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next‐generation sequencing acquired by endoscopic ultrasound–guided FNA and FNB
BackgroundEndoscopic ultrasound–guided tissue acquisition (EUS‐TA), especially endoscopic ultrasound–guided fine‐needle aspiration (EUS‐FNA), is the mainstay of tissue acquisition ...
Comparison of tissue and molecular yield between fine-needle biopsy (FNB) and fine-needle aspiration (FNA): a randomized study
Comparison of tissue and molecular yield between fine-needle biopsy (FNB) and fine-needle aspiration (FNA): a randomized study
Abstract
Background and study aims Recently, a new Franseen design endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) needle was developed with the goal of providi...
Diagnostic accuracy and safety of endoscopic ultrasound-guided fine needle biopsy for evaluating mediastinal pathologies
Diagnostic accuracy and safety of endoscopic ultrasound-guided fine needle biopsy for evaluating mediastinal pathologies
BACKGROUND
The mediastinum comprises vital anatomical structures and can be affected by diverse benign and malignant pathologies. Imaging modalities such as compu...
925 Incremental Value of Endoscopic Ultrasound in Detecting Pancreatic Lesions in Patients With MEN1
925 Incremental Value of Endoscopic Ultrasound in Detecting Pancreatic Lesions in Patients With MEN1
INTRODUCTION:
Multiple endocrine neoplasia type 1 is an inherited disorder that affects the endocrine glands caused by a mutation in the MEN1 gene. MEN1 is associated w...
A review of contrast-enhanced harmonic endoscopic ultrasonography for pancreatic solid tumors
A review of contrast-enhanced harmonic endoscopic ultrasonography for pancreatic solid tumors
AbstractEndoscopic ultrasonography (EUS) is superior to other imaging modalities in the detection of pancreatic masses, although differentiating the types of pancreatic masses dete...
Endoscopic Ultrasound-Guided Fine-Needle Biopsy Versus Aspiration for Tissue Sampling Adequacy for Molecular Testing in Pancreatic Ductal Adenocarcinoma
Endoscopic Ultrasound-Guided Fine-Needle Biopsy Versus Aspiration for Tissue Sampling Adequacy for Molecular Testing in Pancreatic Ductal Adenocarcinoma
Background and Aims: There is limited literature on sample adequacy for molecular testing in pancreatic ductal adenocarcinoma obtained via endoscopic ultrasound (EUS) fine-needle a...
Diagnostic Fine-Needle Biopsy of Small Solid Pancreatic Lesions Using a Franseen Needle during Endoscopic Ultrasound Examination
Diagnostic Fine-Needle Biopsy of Small Solid Pancreatic Lesions Using a Franseen Needle during Endoscopic Ultrasound Examination
Background and aim: During endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNB), Franseen needles can help collect sufficient tissue to permit histopathological ass...
Endoscopic Ultrasound Assessment of Solid Pseudopapillary Neoplasm of the Pancreas: Case Series in Latin American Population
Endoscopic Ultrasound Assessment of Solid Pseudopapillary Neoplasm of the Pancreas: Case Series in Latin American Population
Introduction:
Solid pseudopapillary tumors of the pancreas (SPN) are uncommon lesions. Endoscopic ultrasound is considered the standard examination because of i...

